nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Vandetanib—thyroid cancer	0.49	1	CbGbCtD
Gadobenate Dimeglumine—Skin disorder—Sorafenib—thyroid cancer	0.000824	0.00162	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary embolism—Doxorubicin—thyroid cancer	0.000813	0.0016	CcSEcCtD
Gadobenate Dimeglumine—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.000813	0.0016	CcSEcCtD
Gadobenate Dimeglumine—Injection site reaction—Doxorubicin—thyroid cancer	0.000809	0.00159	CcSEcCtD
Gadobenate Dimeglumine—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000808	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis contact—Doxorubicin—thyroid cancer	0.000804	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Vandetanib—thyroid cancer	0.0008	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Hyperkalaemia—Doxorubicin—thyroid cancer	0.000799	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Rash maculo-papular—Epirubicin—thyroid cancer	0.000799	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Ecchymosis—Epirubicin—thyroid cancer	0.000795	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Rash—Vandetanib—thyroid cancer	0.000793	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Vandetanib—thyroid cancer	0.000792	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00079	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vandetanib—thyroid cancer	0.000788	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary oedema—Epirubicin—thyroid cancer	0.000782	0.00154	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000773	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Hypertonia—Epirubicin—thyroid cancer	0.000771	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Blood urea increased—Doxorubicin—thyroid cancer	0.000768	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Abnormal vision—Epirubicin—thyroid cancer	0.000767	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Sorafenib—thyroid cancer	0.000757	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vandetanib—thyroid cancer	0.000747	0.00147	CcSEcCtD
Gadobenate Dimeglumine—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000747	0.00147	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Sorafenib—thyroid cancer	0.000747	0.00147	CcSEcCtD
Gadobenate Dimeglumine—Phlebitis—Epirubicin—thyroid cancer	0.000741	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000739	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Ecchymosis—Doxorubicin—thyroid cancer	0.000735	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000734	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000733	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Sorafenib—thyroid cancer	0.000732	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00073	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Sorafenib—thyroid cancer	0.000726	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Pain—Sorafenib—thyroid cancer	0.000726	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000724	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Hypertonia—Doxorubicin—thyroid cancer	0.000713	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Abnormal vision—Doxorubicin—thyroid cancer	0.000709	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Eye pain—Epirubicin—thyroid cancer	0.000707	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000704	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000694	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Phlebitis—Doxorubicin—thyroid cancer	0.000685	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000679	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000676	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Sorafenib—thyroid cancer	0.000674	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Sorafenib—thyroid cancer	0.000671	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Sorafenib—thyroid cancer	0.000671	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis bullous—Epirubicin—thyroid cancer	0.000668	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000659	0.00129	CcSEcCtD
Gadobenate Dimeglumine—Eye pain—Doxorubicin—thyroid cancer	0.000654	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Epirubicin—thyroid cancer	0.000654	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Hypoglycaemia—Epirubicin—thyroid cancer	0.000654	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000651	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Epirubicin—thyroid cancer	0.000641	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Pain in extremity—Epirubicin—thyroid cancer	0.000638	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Migraine—Epirubicin—thyroid cancer	0.000628	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Sorafenib—thyroid cancer	0.000625	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000618	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Epirubicin—thyroid cancer	0.000616	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00061	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Sorafenib—thyroid cancer	0.000609	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Epirubicin—thyroid cancer	0.000607	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000605	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Doxorubicin—thyroid cancer	0.000605	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Sorafenib—thyroid cancer	0.0006	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Epirubicin—thyroid cancer	0.000598	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000593	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Pain in extremity—Doxorubicin—thyroid cancer	0.00059	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000589	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Migraine—Doxorubicin—thyroid cancer	0.000581	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Sorafenib—thyroid cancer	0.000581	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000575	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000571	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Doxorubicin—thyroid cancer	0.00057	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000563	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000561	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Sorafenib—thyroid cancer	0.000561	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000553	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Epirubicin—thyroid cancer	0.000551	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000545	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Sorafenib—thyroid cancer	0.00054	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Rash—Sorafenib—thyroid cancer	0.000535	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Sorafenib—thyroid cancer	0.000535	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000532	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Headache—Sorafenib—thyroid cancer	0.000532	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Epirubicin—thyroid cancer	0.00053	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000528	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000521	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Doxorubicin—thyroid cancer	0.00051	0.001	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Epirubicin—thyroid cancer	0.000509	0.001	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Sorafenib—thyroid cancer	0.000504	0.000989	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000497	0.000976	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Epirubicin—thyroid cancer	0.000492	0.000965	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Epirubicin—thyroid cancer	0.000492	0.000965	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—thyroid cancer	0.000491	0.000963	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Epirubicin—thyroid cancer	0.000483	0.000949	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Epirubicin—thyroid cancer	0.000478	0.000938	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Epirubicin—thyroid cancer	0.000478	0.000938	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Epirubicin—thyroid cancer	0.000471	0.000925	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—thyroid cancer	0.000471	0.000925	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Epirubicin—thyroid cancer	0.000469	0.00092	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00046	0.000903	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—thyroid cancer	0.000455	0.000893	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—thyroid cancer	0.000455	0.000893	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Epirubicin—thyroid cancer	0.000449	0.000882	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—thyroid cancer	0.000447	0.000878	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Epirubicin—thyroid cancer	0.000443	0.000868	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000442	0.000868	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000442	0.000868	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000439	0.000862	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—thyroid cancer	0.000436	0.000856	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000436	0.000855	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Epirubicin—thyroid cancer	0.000435	0.000853	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—thyroid cancer	0.000434	0.000851	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000434	0.000851	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Epirubicin—thyroid cancer	0.000433	0.000849	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Epirubicin—thyroid cancer	0.000425	0.000835	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—thyroid cancer	0.000416	0.000816	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—thyroid cancer	0.000413	0.00081	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—thyroid cancer	0.000412	0.000808	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—thyroid cancer	0.00041	0.000804	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—thyroid cancer	0.00041	0.000804	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—thyroid cancer	0.000409	0.000804	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000406	0.000798	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000403	0.000792	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000402	0.00079	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000401	0.000788	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—thyroid cancer	0.0004	0.000786	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—thyroid cancer	0.0004	0.000786	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—thyroid cancer	0.000399	0.000782	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000398	0.000781	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—thyroid cancer	0.000396	0.000777	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—thyroid cancer	0.000394	0.000774	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—thyroid cancer	0.000394	0.000772	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—thyroid cancer	0.000387	0.000759	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—thyroid cancer	0.000384	0.000754	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—thyroid cancer	0.000384	0.000754	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—thyroid cancer	0.000382	0.000749	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—thyroid cancer	0.000381	0.000747	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000379	0.000744	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—thyroid cancer	0.000379	0.000744	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—thyroid cancer	0.000376	0.000738	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—thyroid cancer	0.000372	0.000729	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—thyroid cancer	0.000371	0.000727	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—thyroid cancer	0.000369	0.000725	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—thyroid cancer	0.000369	0.000724	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000368	0.000722	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—thyroid cancer	0.000366	0.000719	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—thyroid cancer	0.000365	0.000716	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—thyroid cancer	0.000358	0.000702	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000357	0.0007	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—thyroid cancer	0.000356	0.000698	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—thyroid cancer	0.000356	0.000698	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—thyroid cancer	0.000355	0.000697	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—thyroid cancer	0.000348	0.000683	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—thyroid cancer	0.000347	0.00068	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—thyroid cancer	0.000345	0.000676	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—thyroid cancer	0.000344	0.000675	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—thyroid cancer	0.000344	0.000675	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—thyroid cancer	0.000342	0.000671	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—thyroid cancer	0.00034	0.000666	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—thyroid cancer	0.000338	0.000663	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—thyroid cancer	0.000335	0.000658	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—thyroid cancer	0.000332	0.000651	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00033	0.000647	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—thyroid cancer	0.000329	0.000645	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—thyroid cancer	0.000327	0.000642	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—thyroid cancer	0.000327	0.000642	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—thyroid cancer	0.000327	0.000642	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—thyroid cancer	0.000326	0.00064	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000325	0.000638	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—thyroid cancer	0.000323	0.000634	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—thyroid cancer	0.000321	0.000629	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—thyroid cancer	0.00032	0.000628	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—thyroid cancer	0.000319	0.000626	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—thyroid cancer	0.000318	0.000625	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—thyroid cancer	0.000316	0.000621	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—thyroid cancer	0.000314	0.000617	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000314	0.000615	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000313	0.000613	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—thyroid cancer	0.000312	0.000611	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—thyroid cancer	0.00031	0.000609	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—thyroid cancer	0.000309	0.000605	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—thyroid cancer	0.000308	0.000604	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—thyroid cancer	0.000307	0.000602	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—thyroid cancer	0.000306	0.000601	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—thyroid cancer	0.000305	0.000598	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000303	0.000595	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—thyroid cancer	0.000303	0.000594	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—thyroid cancer	0.000303	0.000594	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—thyroid cancer	0.000303	0.000594	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—thyroid cancer	0.000302	0.000592	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000301	0.00059	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—thyroid cancer	0.000299	0.000587	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—thyroid cancer	0.000296	0.000581	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—thyroid cancer	0.000293	0.000575	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—thyroid cancer	0.000293	0.000574	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00029	0.000569	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—thyroid cancer	0.000288	0.000566	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000286	0.000561	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—thyroid cancer	0.000285	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000285	0.000558	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—thyroid cancer	0.000283	0.000556	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—thyroid cancer	0.000282	0.000553	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—thyroid cancer	0.000282	0.000553	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000281	0.000551	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—thyroid cancer	0.00028	0.000549	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—thyroid cancer	0.000279	0.000547	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—thyroid cancer	0.000276	0.000542	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—thyroid cancer	0.000271	0.000532	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000271	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—thyroid cancer	0.00027	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—thyroid cancer	0.000268	0.000526	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—thyroid cancer	0.000268	0.000526	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000264	0.000519	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—thyroid cancer	0.000261	0.000511	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—thyroid cancer	0.000259	0.000508	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—thyroid cancer	0.000258	0.000507	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—thyroid cancer	0.000258	0.000506	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000256	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—thyroid cancer	0.000255	0.000501	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000251	0.000492	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—thyroid cancer	0.00025	0.000491	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—thyroid cancer	0.000249	0.000489	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—thyroid cancer	0.000248	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—thyroid cancer	0.000248	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—thyroid cancer	0.000248	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—thyroid cancer	0.000248	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000239	0.000469	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000237	0.000466	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—thyroid cancer	0.000231	0.000453	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—thyroid cancer	0.000231	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—thyroid cancer	0.000229	0.00045	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—thyroid cancer	0.000229	0.00045	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Epirubicin—thyroid cancer	0.000225	0.000442	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—thyroid cancer	0.000222	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—thyroid cancer	0.000215	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000214	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—thyroid cancer	0.000208	0.000409	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Epirubicin—thyroid cancer	0.000207	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—thyroid cancer	0.000205	0.000403	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Epirubicin—thyroid cancer	0.000199	0.000391	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—thyroid cancer	0.000199	0.00039	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—thyroid cancer	0.000198	0.000388	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—thyroid cancer	0.000198	0.000388	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—thyroid cancer	0.000196	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—thyroid cancer	0.000192	0.000377	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Epirubicin—thyroid cancer	0.000186	0.000366	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—thyroid cancer	0.000184	0.000362	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—thyroid cancer	0.000183	0.000359	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—thyroid cancer	0.000183	0.000359	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—thyroid cancer	0.000182	0.000357	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—thyroid cancer	0.000172	0.000338	CcSEcCtD
